In two models of intraperitoneal ovarian cancer, the AXL-DNA-APTAMER suppresses metastasis, migration/invasion and tumor growth on its own and enhances the effects of paclitaxel treatment [172], presumably by disrupting focal adhesion kinase (FAK) phosphorylation and matrix-metalloproteinases. The gene discussed is AXL; the disease is ovarian carcinoma.